Rebecca Taub insider trades

Open-market stock purchases and sales by Rebecca Taub, Director at Madrigal Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 22, 2016.

Recent trades

DateStockTradeValue
Jun 17, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Jun 17, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Mar 6, 2026MDGL Madrigal Pharmaceuticals, IncSold$212K
Jan 26, 2026MDGL Madrigal Pharmaceuticals, IncSold$319K
Jan 20, 2026MDGL Madrigal Pharmaceuticals, IncSold$1.1M
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$21.8K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$383K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$700K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$246K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$293K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$136K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$15.9K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$145K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$47.6K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$160K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$207K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$493K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$482K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$814K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$269K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$1.1M
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$503K
Jan 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$280K

Companies traded

  • MDGL Madrigal Pharmaceuticals, Inc: 88 sales, last Jun 17, 2026

Get free alerts when Rebecca Taub files a new trade →